]>
IRCT20150825023753N6 IRCT 2018-05-03 Shahid Beheshti University of Medical Sciences Effects of "nokhod-ab" on fatigue in cancerous patients Effects of "nokhod-ab" on cancer-related fatigue in cancer patients 2018-01-05 anticipated 40 Complete https://irct.ir/trial/30467 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 3 Neoplastic (malignant) related fatigue. Intervention group:Administrating 80 ml "nokhod-ab" three times a day for three weeks. Yes - There is a plan to make this available What will be shared: Demographic data and the result of the clinical trial When: 6 month later To whom: Researchers Conditions: After publication of the extracted article of the clinical trial Where to obtain: Sending Email to the researchers How to obtain: Sending the request via the email Comments:
public Dr. Ghazaleh Heydarirad
Shams Alley, Vali-e-Asr Street, Shahid Beheshti University of Medical Sciences
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 6027 ghazalrad@yahoo.com Shahid Beheshti University of Medical Sciences scientific Dr Rasool Choopani
Shams Alley, Vali-e-Asr Street, Shahid Beheshti University of Medical Sciences
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3523 rchoopani@sbmu.ac.ir Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Age between 18- 70 years old Patients known case of cancer Hemoglobin level is at least 8 g / dl Hematocrit level at least 30% The level of TSH is normal 18 years 70 years Both Patients known case of heart disease with unstable conditions Disabling Pulmonary Disease and History of Asthma Patients known case of severe kidney disease Creatinine level is greater than 2mg / dl Proteinuria The SGOT level is more than 3 times of the normal threshold Bilirubin levels is greater than 2mg / dl Positive history of hypersensitivity to saffron, cinnamon, peas Uncontrolled pain, severe infection, serious illness Positive history of gout or high level of uric acid An individual who uses antidepressants due to depression Simultaneous use of drugs that affect fatigue Unwillingness to participate in the study R53.0 Neoplastic (malignant) related fatigue Treatment - Drugs Intervention group:Administrating 80 ml "nokhod-ab" three times a day for three weeks Score of Fatigue Severity "Visual Analogue Fatigue Scale". Timepoint: Three weeks. Method of measurement: Using Visual Analogue Fatigue Scale questionnaire. Score of "Fatigue Severity". Timepoint: Three weeks. Method of measurement: Fatigue Severity Scale questionnaire. Score of "The Cancer Fatigue Scale". Timepoint: Three weeks. Method of measurement: The Cancer Fatigue Scale questionnaire. Shahid Beheshti University of Medical Sciences Approved 2017-07-23 Ethics Committee on Biomedical Research of Shahid Beheshti University of Medical sciences Shahid Beheshti University of Medical sciences, Daneshju Blv. Tehran Tehran Iran (Islamic Republic of)